Previous close | 67.00 |
Open | 67.50 |
Bid | 67.50 x 0 |
Ask | 68.00 x 0 |
Day's range | 67.50 - 67.50 |
52-week range | 57.50 - 125.00 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights CONMED's estimated fair value is US$142 based on 2 Stage Free Cash Flow to Equity CONMED is estimated to...
In this article, we will take a detailed look at the 10 Worst-Performing Stocks Insiders are Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Worst-Performing Stocks Insiders are Buying in 2024. Expert money managers and investors have always advised individual investors to not fret over […]
On April 30, 2024, Pat Beyer, Chief Operating Officer of Conmed Corp (NYSE:CNMD), purchased 3,000 shares of the company, as reported in a recent SEC Filing.